Serial Number 88756336
606

Registration Progress

Application Filed
Jan 13, 2020
Under Examination
May 12, 2020
Approved for Publication
Mar 17, 2020
Published for Opposition
Mar 17, 2020
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark:
Previous Owner: PLx Pharma Inc.
Classes: 005

Trademark Image

Basic Information

Serial Number
88756336
Filing Date
January 13, 2020
Published for Opposition
March 17, 2020
Abandonment Date
June 12, 2023
Drawing Code
2

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jun 12, 2023
Classes
005

Rights Holder

PLx Pharma Inc.

03
Address
9 Fishers Lane
Sparta, NJ 07871

Ownership History

PLx Pharma Inc.

Original Applicant
03
Sparta, NJ

PLx Pharma Inc.

Owner at Publication
03
Sparta, NJ

Legal Representation

Attorney
Mary L. Grieco

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

44 events
Date Code Type Description Documents
Jun 12, 2023 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jun 12, 2023 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Oct 18, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 17, 2022 EX5G S SOU EXTENSION 5 GRANTED Loading...
Oct 14, 2022 EXT5 S SOU EXTENSION 5 FILED Loading...
Oct 14, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
May 7, 2022 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
May 5, 2022 EX4G S SOU EXTENSION 4 GRANTED Loading...
May 5, 2022 EXT4 S SOU EXTENSION 4 FILED Loading...
May 5, 2022 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 3, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 1, 2021 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 1, 2021 EXT3 S SOU EXTENSION 3 FILED Loading...
Nov 1, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Apr 14, 2021 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Apr 12, 2021 EX2G S SOU EXTENSION 2 GRANTED Loading...
Apr 12, 2021 EXT2 S SOU EXTENSION 2 FILED Loading...
Apr 12, 2021 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 28, 2020 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Oct 26, 2020 EX1G S SOU EXTENSION 1 GRANTED Loading...
Oct 26, 2020 EXT1 S SOU EXTENSION 1 FILED Loading...
Oct 26, 2020 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Oct 27, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Oct 27, 2020 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Sep 15, 2020 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED Loading...
Aug 28, 2020 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Aug 28, 2020 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Aug 28, 2020 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
May 12, 2020 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 17, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 17, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Feb 26, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 12, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Feb 12, 2020 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Feb 11, 2020 ALIE A ASSIGNED TO LIE Loading...
Feb 6, 2020 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 6, 2020 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Feb 6, 2020 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Feb 6, 2020 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Feb 6, 2020 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Feb 6, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 17, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Jan 16, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 16, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Aspirin-based analgesic, anti-pyretic and anti-inflammatory oral preparations in liquid-filled capsules and oral preparations in liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention

Additional Information

Design Mark
The mark consists of a heart design overlaid with an electrocardiograph line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005